CA2369000C - Systeme et methode de raccordement fluidique - Google Patents
Systeme et methode de raccordement fluidique Download PDFInfo
- Publication number
- CA2369000C CA2369000C CA002369000A CA2369000A CA2369000C CA 2369000 C CA2369000 C CA 2369000C CA 002369000 A CA002369000 A CA 002369000A CA 2369000 A CA2369000 A CA 2369000A CA 2369000 C CA2369000 C CA 2369000C
- Authority
- CA
- Canada
- Prior art keywords
- membrane
- tube
- extending
- sheath
- conduit
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Lifetime
Links
- 238000000034 method Methods 0.000 title claims description 27
- 239000012528 membrane Substances 0.000 claims abstract description 73
- 239000000853 adhesive Substances 0.000 claims abstract description 16
- 230000001070 adhesive effect Effects 0.000 claims abstract description 16
- 239000000463 material Substances 0.000 claims description 36
- 210000003899 penis Anatomy 0.000 claims description 16
- 238000007789 sealing Methods 0.000 claims description 4
- 241000973497 Siphonognathus argyrophanes Species 0.000 claims description 2
- 206010052428 Wound Diseases 0.000 description 107
- 208000027418 Wounds and injury Diseases 0.000 description 107
- 239000012530 fluid Substances 0.000 description 58
- 239000010410 layer Substances 0.000 description 15
- 208000015181 infectious disease Diseases 0.000 description 13
- 230000009471 action Effects 0.000 description 11
- 239000007788 liquid Substances 0.000 description 11
- 230000035876 healing Effects 0.000 description 10
- 210000002700 urine Anatomy 0.000 description 9
- 230000006870 function Effects 0.000 description 8
- 239000011248 coating agent Substances 0.000 description 7
- 238000000576 coating method Methods 0.000 description 7
- 230000005484 gravity Effects 0.000 description 6
- 239000003102 growth factor Substances 0.000 description 6
- 239000000243 solution Substances 0.000 description 6
- 239000003242 anti bacterial agent Substances 0.000 description 5
- 229940088710 antibiotic agent Drugs 0.000 description 5
- 238000002347 injection Methods 0.000 description 5
- 239000007924 injection Substances 0.000 description 5
- 230000001681 protective effect Effects 0.000 description 5
- 230000008901 benefit Effects 0.000 description 4
- 239000003814 drug Substances 0.000 description 4
- 229940079593 drug Drugs 0.000 description 4
- 239000004033 plastic Substances 0.000 description 4
- 229920003023 plastic Polymers 0.000 description 4
- 230000001737 promoting effect Effects 0.000 description 4
- 229920000297 Rayon Polymers 0.000 description 3
- 208000002847 Surgical Wound Diseases 0.000 description 3
- 208000025865 Ulcer Diseases 0.000 description 3
- 230000003466 anti-cipated effect Effects 0.000 description 3
- 230000008859 change Effects 0.000 description 3
- 230000001419 dependent effect Effects 0.000 description 3
- 210000000416 exudates and transudate Anatomy 0.000 description 3
- 230000036074 healthy skin Effects 0.000 description 3
- 239000006193 liquid solution Substances 0.000 description 3
- 238000002483 medication Methods 0.000 description 3
- 239000002964 rayon Substances 0.000 description 3
- 231100000397 ulcer Toxicity 0.000 description 3
- 229920001605 Dextranomer Polymers 0.000 description 2
- 102000009024 Epidermal Growth Factor Human genes 0.000 description 2
- 102000009123 Fibrin Human genes 0.000 description 2
- 108010073385 Fibrin Proteins 0.000 description 2
- BWGVNKXGVNDBDI-UHFFFAOYSA-N Fibrin monomer Chemical compound CNC(=O)CNC(=O)CN BWGVNKXGVNDBDI-UHFFFAOYSA-N 0.000 description 2
- 238000009825 accumulation Methods 0.000 description 2
- 230000008878 coupling Effects 0.000 description 2
- 238000010168 coupling process Methods 0.000 description 2
- 238000005859 coupling reaction Methods 0.000 description 2
- 206010012601 diabetes mellitus Diseases 0.000 description 2
- 229950003499 fibrin Drugs 0.000 description 2
- 230000036541 health Effects 0.000 description 2
- 239000000416 hydrocolloid Substances 0.000 description 2
- 238000001990 intravenous administration Methods 0.000 description 2
- 230000000670 limiting effect Effects 0.000 description 2
- 238000004519 manufacturing process Methods 0.000 description 2
- 230000037368 penetrate the skin Effects 0.000 description 2
- 230000002980 postoperative effect Effects 0.000 description 2
- 230000002829 reductive effect Effects 0.000 description 2
- 230000008929 regeneration Effects 0.000 description 2
- 238000011069 regeneration method Methods 0.000 description 2
- 210000002966 serum Anatomy 0.000 description 2
- 210000003708 urethra Anatomy 0.000 description 2
- 241000191291 Abies alba Species 0.000 description 1
- 206010056948 Automatic bladder Diseases 0.000 description 1
- 206010053567 Coagulopathies Diseases 0.000 description 1
- XZMCDFZZKTWFGF-UHFFFAOYSA-N Cyanamide Chemical compound NC#N XZMCDFZZKTWFGF-UHFFFAOYSA-N 0.000 description 1
- 101100506443 Danio rerio helt gene Proteins 0.000 description 1
- 101800003838 Epidermal growth factor Proteins 0.000 description 1
- IAYPIBMASNFSPL-UHFFFAOYSA-N Ethylene oxide Chemical compound C1CO1 IAYPIBMASNFSPL-UHFFFAOYSA-N 0.000 description 1
- 108010049003 Fibrinogen Proteins 0.000 description 1
- 102000008946 Fibrinogen Human genes 0.000 description 1
- 206010021639 Incontinence Diseases 0.000 description 1
- 101100506445 Mus musculus Helt gene Proteins 0.000 description 1
- 206010033892 Paraplegia Diseases 0.000 description 1
- 239000004952 Polyamide Substances 0.000 description 1
- 239000002202 Polyethylene glycol Substances 0.000 description 1
- 229920005830 Polyurethane Foam Polymers 0.000 description 1
- 206010040943 Skin Ulcer Diseases 0.000 description 1
- 206010072170 Skin wound Diseases 0.000 description 1
- 108090000190 Thrombin Proteins 0.000 description 1
- 230000001464 adherent effect Effects 0.000 description 1
- 239000012790 adhesive layer Substances 0.000 description 1
- 239000007864 aqueous solution Substances 0.000 description 1
- 239000011324 bead Substances 0.000 description 1
- 210000004369 blood Anatomy 0.000 description 1
- 239000008280 blood Substances 0.000 description 1
- 230000017531 blood circulation Effects 0.000 description 1
- 239000004568 cement Substances 0.000 description 1
- 238000004140 cleaning Methods 0.000 description 1
- 230000035602 clotting Effects 0.000 description 1
- 230000015271 coagulation Effects 0.000 description 1
- 238000005345 coagulation Methods 0.000 description 1
- 239000000084 colloidal system Substances 0.000 description 1
- 230000006835 compression Effects 0.000 description 1
- 238000007906 compression Methods 0.000 description 1
- 201000003146 cystitis Diseases 0.000 description 1
- 230000003247 decreasing effect Effects 0.000 description 1
- 229960002864 dextranomer Drugs 0.000 description 1
- 238000002405 diagnostic procedure Methods 0.000 description 1
- 238000009826 distribution Methods 0.000 description 1
- 229920001971 elastomer Polymers 0.000 description 1
- 229940116977 epidermal growth factor Drugs 0.000 description 1
- 210000003414 extremity Anatomy 0.000 description 1
- 229940012952 fibrinogen Drugs 0.000 description 1
- 239000011888 foil Substances 0.000 description 1
- 210000000245 forearm Anatomy 0.000 description 1
- 230000008676 import Effects 0.000 description 1
- 230000036512 infertility Effects 0.000 description 1
- 208000014674 injury Diseases 0.000 description 1
- 230000007794 irritation Effects 0.000 description 1
- 230000002879 macerating effect Effects 0.000 description 1
- 239000002184 metal Substances 0.000 description 1
- 238000005065 mining Methods 0.000 description 1
- 210000005036 nerve Anatomy 0.000 description 1
- 238000004806 packaging method and process Methods 0.000 description 1
- 230000036961 partial effect Effects 0.000 description 1
- 230000002093 peripheral effect Effects 0.000 description 1
- 230000035699 permeability Effects 0.000 description 1
- 229920002647 polyamide Polymers 0.000 description 1
- 229920001223 polyethylene glycol Polymers 0.000 description 1
- 229940057847 polyethylene glycol 600 Drugs 0.000 description 1
- 229920002635 polyurethane Polymers 0.000 description 1
- 239000004814 polyurethane Substances 0.000 description 1
- 239000011496 polyurethane foam Substances 0.000 description 1
- 238000002360 preparation method Methods 0.000 description 1
- 230000008569 process Effects 0.000 description 1
- 230000004044 response Effects 0.000 description 1
- 238000005070 sampling Methods 0.000 description 1
- 230000028327 secretion Effects 0.000 description 1
- 238000004513 sizing Methods 0.000 description 1
- 231100000019 skin ulcer Toxicity 0.000 description 1
- 230000001502 supplementing effect Effects 0.000 description 1
- 230000008961 swelling Effects 0.000 description 1
- 229920002994 synthetic fiber Polymers 0.000 description 1
- SRVJKTDHMYAMHA-WUXMJOGZSA-N thioacetazone Chemical compound CC(=O)NC1=CC=C(\C=N\NC(N)=S)C=C1 SRVJKTDHMYAMHA-WUXMJOGZSA-N 0.000 description 1
- 229960004072 thrombin Drugs 0.000 description 1
- 239000003053 toxin Substances 0.000 description 1
- 231100000765 toxin Toxicity 0.000 description 1
- 108700012359 toxins Proteins 0.000 description 1
- 230000008733 trauma Effects 0.000 description 1
- 208000019206 urinary tract infection Diseases 0.000 description 1
- VBEQCZHXXJYVRD-GACYYNSASA-N uroanthelone Chemical compound C([C@@H](C(=O)N[C@H](C(=O)N[C@@H](CS)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CS)C(=O)N[C@H](C(=O)N[C@@H]([C@@H](C)CC)C(=O)NCC(=O)N[C@@H](CC=1C=CC(O)=CC=1)C(=O)N[C@@H](CO)C(=O)NCC(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CS)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CC=1C2=CC=CC=C2NC=1)C(=O)N[C@@H](CC=1C2=CC=CC=C2NC=1)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCNC(N)=N)C(O)=O)C(C)C)[C@@H](C)O)NC(=O)[C@H](CO)NC(=O)[C@H](CC(O)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CO)NC(=O)[C@H](CCC(O)=O)NC(=O)[C@@H](NC(=O)[C@H](CC=1NC=NC=1)NC(=O)[C@H](CCSC)NC(=O)[C@H](CS)NC(=O)[C@@H](NC(=O)CNC(=O)CNC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CS)NC(=O)[C@H](CC=1C=CC(O)=CC=1)NC(=O)CNC(=O)[C@H](CC(O)=O)NC(=O)[C@H](CC=1C=CC(O)=CC=1)NC(=O)[C@H](CO)NC(=O)[C@H](CO)NC(=O)[C@H]1N(CCC1)C(=O)[C@H](CS)NC(=O)CNC(=O)[C@H]1N(CCC1)C(=O)[C@H](CC=1C=CC(O)=CC=1)NC(=O)[C@H](CO)NC(=O)[C@@H](N)CC(N)=O)C(C)C)[C@@H](C)CC)C1=CC=C(O)C=C1 VBEQCZHXXJYVRD-GACYYNSASA-N 0.000 description 1
- 208000019553 vascular disease Diseases 0.000 description 1
- 201000002282 venous insufficiency Diseases 0.000 description 1
- 230000002747 voluntary effect Effects 0.000 description 1
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 1
- 210000000707 wrist Anatomy 0.000 description 1
Landscapes
- Materials For Medical Uses (AREA)
- Orthopedics, Nursing, And Contraception (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US332,699 | 1989-04-03 | ||
| US07/332,699 US4969880A (en) | 1989-04-03 | 1989-04-03 | Wound dressing and treatment method |
| CA002049948A CA2049948C (fr) | 1989-04-03 | 1990-04-03 | Systeme et methode de raccordement fluidique |
Related Parent Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CA002049948A Division CA2049948C (fr) | 1989-04-03 | 1990-04-03 | Systeme et methode de raccordement fluidique |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| CA2369000A1 CA2369000A1 (fr) | 1990-10-18 |
| CA2369000C true CA2369000C (fr) | 2007-02-06 |
Family
ID=25674749
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CA002369000A Expired - Lifetime CA2369000C (fr) | 1989-04-03 | 1990-04-03 | Systeme et methode de raccordement fluidique |
Country Status (1)
| Country | Link |
|---|---|
| CA (1) | CA2369000C (fr) |
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US9452248B2 (en) | 2003-10-28 | 2016-09-27 | Smith & Nephew Plc | Wound cleansing apparatus in-situ |
Families Citing this family (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US7846141B2 (en) | 2002-09-03 | 2010-12-07 | Bluesky Medical Group Incorporated | Reduced pressure treatment system |
| GB0224986D0 (en) | 2002-10-28 | 2002-12-04 | Smith & Nephew | Apparatus |
| US7128735B2 (en) | 2004-01-02 | 2006-10-31 | Richard Scott Weston | Reduced pressure wound treatment appliance |
| US7776028B2 (en) | 2004-04-05 | 2010-08-17 | Bluesky Medical Group Incorporated | Adjustable overlay reduced pressure wound treatment system |
| US7708724B2 (en) | 2004-04-05 | 2010-05-04 | Blue Sky Medical Group Incorporated | Reduced pressure wound cupping treatment system |
| US8062272B2 (en) | 2004-05-21 | 2011-11-22 | Bluesky Medical Group Incorporated | Flexible reduced pressure treatment appliance |
| US7998125B2 (en) | 2004-05-21 | 2011-08-16 | Bluesky Medical Group Incorporated | Hypobaric chamber treatment system |
-
1990
- 1990-04-03 CA CA002369000A patent/CA2369000C/fr not_active Expired - Lifetime
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US9452248B2 (en) | 2003-10-28 | 2016-09-27 | Smith & Nephew Plc | Wound cleansing apparatus in-situ |
Also Published As
| Publication number | Publication date |
|---|---|
| CA2369000A1 (fr) | 1990-10-18 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US5100396A (en) | Fluidic connection system and method | |
| EP0465601B1 (fr) | Systeme de passage de fluide | |
| CA2103033C (fr) | Pansement | |
| US5527293A (en) | Fastening system and method | |
| US20210228417A1 (en) | Conformable medical dressing with self supporting substrate | |
| US9572962B2 (en) | Medical dressings with valve and kits containing same | |
| US7731702B2 (en) | Closed wound drainage system | |
| EP2103290B1 (fr) | Pansement de thérapie sous vide doté de zones de performance variable | |
| EP1487389B1 (fr) | Acces d'un catheter exterieur a un pansement sous vide | |
| US20080103489A1 (en) | Vacuum adherent dressings, systems and methods of use for same | |
| US20130317405A1 (en) | Modular wound dressing | |
| US20080208171A1 (en) | Device and method for removing edema | |
| EP2959933A1 (fr) | Système à vide avec orifice de vide pour un traitement des plaies par pression négative | |
| CA2369000C (fr) | Systeme et methode de raccordement fluidique | |
| CA2414393A1 (fr) | Systeme de fixation et methode connexe |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| EEER | Examination request | ||
| MKEX | Expiry |